section name header

Indications

REMS

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

Derm: hot flush.

GI: ↑ liver enzymes, abdominal pain, diarrhea.

MS: back pain.

Neuro: insomnia.

Interactions

Drug-Drug:

Availability

Route/Dosage

US Brand Names

Veozah

Action

Therapeutic Effects:

Classifications

Therapeutic Classification:

Pharmacologic Classification: neurokinin 3 receptor antagonists

Pharmacokinetics

Absorption: Extent of absorption unknown.

Distribution: Extensively distributed to tissues.

Metabolism/Excretion: Primarily metabolized by the liver via the CYP1A2 isonezyme, with some metabolism by the CYP2C9 and CYP2C19 isoenzymes. Primarily excreted in the urine (77%; 1% as unchanged drug), with 15% excreted in the feces (<1% as unchanged drug).

Half-life: 9.6 hr.

Time/Action Profile

(plasma concentrations)

ROUTEONSETPEAKDURATION
POunknown1–4 hr24 hr

Patient/Family Teaching

Pronunciation

FEZ-oh-LIN-e-tant